Drug Approval | September 30, 2024
USFDA completes inspection at Biocon Biologics’ Insulins facility at Malaysia
The inspection concluded with the issuance of a form 483 with five observations
The inspection concluded with the issuance of a form 483 with five observations
The net-zero target approval complements the company's near-term emission reduction targets
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
New Phase II data show vast majority of patients experiencing no relapses or disability progression
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Subscribe To Our Newsletter & Stay Updated
